-
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer(CORECT): Meta-analysis
Study
phs001499
-
Multi-omics bulk and single-cell profiling of epithelioid sarcoma
Study
EGAS50000000973
-
Identification_of_synthetic_lethal_genes_by_CRISPR_Cas9_library
Study
EGAS00001002117
-
Germline variants collaborate with somatic mutations and initiate and/or drive disease in primary myelodysplastic syndrome (MDS) and therapy-related myeloid neoplasms (t-MN)
Study
EGAS00001003547
-
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized controlled trial AGITG-MAX
Study
EGAS00001005453
-
CIDR, NCI, NIDA Sequencing of Targeted Genomic Regions Associated with Smoking
Study
phs000813
-
ALCHEMIST Study
Study
phs001140
-
Adipose Tissue Omics In Obesity
Study
phs003390
-
Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick)
Study
phs003099
-
Gene Expression Study of Individuals with Sex Chromosome Aneuploidies
Study
phs002481
-
Recurrent DNMT3B gene rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
Study
EGAS00001007383
-
High-Resolution Clonal Mapping of Multi-Organ Metastasis, and Resistance to Neoadjuvant Chemotherapy, in Triple Negative Breast Cancer
Study
phs001742
-
Surgery in combination with immune checkpoint therapy as an effective treatment for patients with metastatic cancer.
Study
EGAS00001005667
-
Complex genotype-phenotype relationships shape the response to treatment of Down Syndrome Childhood Acute Lymphoblastic Leukaemia
Study
EGAS50000001287
-
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS50000000106
-
Breast cancer DNA repair
Study
EGAS00001002792
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Study
EGAS50000000710
-
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification and exhaustion in multiple myeloma
Study
EGAS50000000304
-
Discovery and validation of an ancillary genomic test of malignancy for primary melanocytic tumors
Study
EGAS50000000887
-
Convergent evolution towards CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Study
EGAS50000000709
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
Study of Melanoma Risk in Australia and the United Kingdom
Study
phs000519